04 September 2020: Original Paper
Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells
Zhuo-Qing Li 1BCDEF* , Hong Shen 2BCDE* , Kun-Xian Shu 3BCDF , Jian-Jun Li 1BCDF , Yin Tang 4BCD , Jing-Jing Su 4BCF , Jun Yan 1BCD , Jie Yang 3BCF , Ze-Qing Wang 1BCF , Yan Qiu 4BC , Yong Yang 1CF , Yang Liu 4CF , Yong Zhou 5BDEG*DOI: 10.12659/AOT.925013
Ann Transplant 2020; 25:e925013
Figure 6 Production of C-caspase 3 and cytochrome C proteins in tumor cells and normal cells. (A) Western blot images. Relative C-caspase 3 and cytochrome C expression in HepG2 (B), A549 (C), BGC-803 (D), and HUVEC (E) was statistically analyzed. 1 – Tumor cells (HepG2, A549, BGC-803, or HUVEC cells) without transfection, 2 – Tumor cells (HepG2, A549, BGC-803, or HUVEC cells) transfected with pAAV-IRES-ZsGreen, pHelper, and pAAV-RC, 3 – Tumor cells (HepG2, A549, BGC-803, or HUVEC cells) transfected with pAAV-HE1B19K-TE1A, pHelper, and pAAV-RC). * p<0.05 vs. pAAV-IRES-ZsGreen group in HepG2, A549, or BGC-803 cells.